Skip to main content

Table 3 Hemodynamic variations and therapeutic interventions from H7 to H12

From: Benefits of an early cooling phase in continuous renal replacement therapy for ICU patients

  Group A Group B Pintergroup
  Period 2 Temp 36°C Period 2 Temp 38°C  
  n = 11 n = 11  
  H7 H12 H12-H6 P Intra- group H7 H12 H12-H7 P Intra- group H12-H7
SAP mmHg 124 [21] 125 [18] 1.1 [21.1] 0.66 121 [27] 122 [25] 1.5[12.8] 0.48 0.07
DAP mmHg 62 [12] 58 [10] −3.5 [10.7] 0.45 60 [5] 64 [10] 3.7 [10] 0.18 0.16
MAP mmHg 79 [15] 79 [11] −0.9 [12.3] 0.88 80 [10] 83 [13] 2.5 [9.9] 0.33 0.53
HR beat/min 88 [16] 89 [12] 1.4 [12.3] 0.99 105 [23] 102 [23] −2.8 [6.4] 0.2 0.69
Lactates (mmol/L) 4.9 [5.7] 5.6 [6.8] 0.6 [1.4] 0.33 2.2 [1.6] 2.4 [1.9] 0.2 [0.3] 0.21 0.64
Nep dosage μg/kg/min 0.76 [1.01] 0.81 [1.13] 0.05 [0.3] 0.89 0.64 [0.58] 0.66 [0.63] −0.02 [0.1] 0.67 0.99
Increase of CA dose (no. patients) 2 4  
Decrease of CA dose (no. patients) 4 2  
Fluid infusion (n of patients) 3 0  
Total volume infused (ml) 3500 0  
Therapeutic action (no. patients) 3 4  
  1. Values are expressed as mean [SD] or median (interquartile range); SAP systolic arterial pressure, DAP diastolic arterial pressure, MAP mean arterial pressure, CA catecholamine, Nep norepinephrine. Therapeutic action: fluid infusion or increase dosage of catecholamine.